109 related articles for article (PubMed ID: 26467564)
21. [Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice].
Ma XY; Li S; Luo DF; Liu RH; Lu YP; Wang SX; Ma D; Xi L
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):737-41. PubMed ID: 24378093
[TBL] [Abstract][Full Text] [Related]
22. TSU-68 (SU6668) inhibits local tumor growth and liver metastasis of human colon cancer xenografts via anti-angiogenesis.
Yorozuya K; Kubota T; Watanabe M; Hasegawa H; Ozawa S; Kitajima M; Chikahisa LM; Yamada Y
Oncol Rep; 2005 Sep; 14(3):677-82. PubMed ID: 16077974
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.
Narayanan NK; Kunimasa K; Yamori Y; Mori M; Mori H; Nakamura K; Miller G; Manne U; Tiwari AK; Narayanan B
Cancer Med; 2015 Nov; 4(11):1767-80. PubMed ID: 26408414
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.
Qin Y; Van Cauteren M; Osteaux M; Schally AV; Willems G
Cancer Res; 1992 Nov; 52(21):6025-30. PubMed ID: 1356623
[TBL] [Abstract][Full Text] [Related]
25. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
[TBL] [Abstract][Full Text] [Related]
26. Targeting interleukin-4 receptor α with hybrid peptide for effective cancer therapy.
Yang L; Horibe T; Kohno M; Haramoto M; Ohara K; Puri RK; Kawakami K
Mol Cancer Ther; 2012 Jan; 11(1):235-43. PubMed ID: 22084165
[TBL] [Abstract][Full Text] [Related]
27. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent.
Kawamoto M; Kohno M; Horibe T; Kawakami K
Cancer Chemother Pharmacol; 2013 Mar; 71(3):799-807. PubMed ID: 23328867
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
30. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer.
Bäumer S; Bäumer N; Appel N; Terheyden L; Fremerey J; Schelhaas S; Wardelmann E; Buchholz F; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Mar; 21(6):1383-94. PubMed ID: 25589625
[TBL] [Abstract][Full Text] [Related]
31. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
Zhou M; Mok MT; Sun H; Chan AW; Huang Y; Cheng AS; Xu G
Oncogene; 2017 Jul; 36(29):4135-4149. PubMed ID: 28319060
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).
Bianco C; Tortora G; Bianco R; Caputo R; Veneziani BM; Caputo R; Damiano V; Troiani T; Fontanini G; Raben D; Pepe S; Bianco AR; Ciardiello F
Clin Cancer Res; 2002 Oct; 8(10):3250-8. PubMed ID: 12374696
[TBL] [Abstract][Full Text] [Related]
34. Characterization of antilytic peptide antibody: application for the detection of lytic-based hybrid peptide in serum samples.
Ohara K; Horibe T; Kohno M; Kawakami K
J Pept Sci; 2011 Jul; 17(7):493-8. PubMed ID: 21351323
[TBL] [Abstract][Full Text] [Related]
35. Antimetastatic effect of hepatotropic liposomal adriamycin on human metastatic liver tumors.
Matsuda I; Konno H; Tanaka T; Nakamura S
Surg Today; 2001; 31(5):414-20. PubMed ID: 11381505
[TBL] [Abstract][Full Text] [Related]
36. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
[TBL] [Abstract][Full Text] [Related]
37. Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta.
Ozawa S; Lu W; Bucana CD; Kanayama HO; Shinohara H; Fidler IJ; Dong Z
Int J Oncol; 2003 May; 22(5):977-84. PubMed ID: 12684662
[TBL] [Abstract][Full Text] [Related]
38. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
39. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
[TBL] [Abstract][Full Text] [Related]
40. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G
Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
